Theravance Biopharma logo
Theravance Biopharma TBPH
$ 8.27 -0.18%

Квартальный отчет 2024-Q2
добавлен 08.08.2024

report update icon

Theravance Biopharma Мультипликаторы 2011-2024 | TBPH

Мультипликаторы по годам Theravance Biopharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-61.0 -72.8 -19.8 -4.2 -6.6 -6.3 -5.0 -6.6 -3.1 -2.2 - - -

P/S

29.6 51.5 42.3 16.2 21.2 22.5 91.8 26.0 13.3 44.1 - - -

EPS

-0.2 -0.1 -0.4 -4.5 -4.2 -4.0 -5.5 -4.3 -5.3 -7.5 -4.9 -0.3 -

EV (Enterprise Value)

480 млн 456 млн 543 млн 1.08 млрд 2.13 млрд 1.59 млрд 1.65 млрд 1.21 млрд 505 млн 474 млн 42.2 млн - -

EBITDA per Share

-0.08 -0.2 -0.76 -4.72 -4.41 -4.37 -5.04 -3.97 -5.24 -7.22 - - -

EV/EBITDA

-2.1 -3.8 -8.0 -6.1 -5.9 -6.4 -2.5 -1.9 - - -

PEG

1.46 2.23 1.59 8.27 1.02 -0.24 0.18 -0.33 -0.11 0.04 - - -

P/B

1.4 1.2 1.7 2.5 -6.9 -26.3 12.3 3.6 2.3 1.8 - - -

P/CF

-19.2 -4.0 -3.0 -4.6 -6.4 -11.3 -6.9 -12.5 -3.3 -2.9 - - -

ROE %

-4.00 -2.35 9.46 91.53 105.64 417.77 -247.79 -54.44 -74.97 -81.80 - - -

ROA %

-2.23 -1.71 -8.55 -59.27 -57.84 -38.47 -64.66 -29.83 -60.72 -70.18 - - -

ROCE %

-2.93 -3.95 16.59 97.98 -84.78 -51.71 -70.77 -30.59 -72.57 -78.42 - - -

Current Ratio

- - - - 3.0 5.4 6.1 10.7 4.8 6.7 - - -

DSO

- - - - 251.4 64.5 222.1 72.9 321.9 66.5 - - -

DIO

- - - - - - 1018.7 1541.2 784.2 1128.5 - - -

DPO

- - - - - 4608.7 358.6 218.6 1473.8 892.4 - - -

Операционный цикл

- - - - - 64.5 1240.8 1614.2 1106.1 1194.9 - - -

Финансовый цикл

- - - - - -4544.2 882.2 1395.6 -367.7 302.6 - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Theravance Biopharma

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.34 -0.24 - -0.17 -0.28 -0.35 - 12.14 -0.11 -0.34 -0.43 -0.48 -0.8 -1.24 -0.92 -1.16 -1 -1.4 -1.17 -1.05 -0.72 -1.32 -0.92 -1.1 -0.76 -1.22 -1.64 -1.27 -1.27 -1.27 -1.36 -0.73 -1.06 -1.1 -1.23 -1.4 -1.42 -1.29 -2.02 -1.72 -1.83 -1.89 -1.39 -1.29 -1.23 -1.01 - - - - - - - -

EBITDA per Share

- - - - - - - -0.19 -0.3 -0.49 -0.75 -0.73 -0.98 -1.3 -1.19 -1.21 -1.14 -1.21 -1.24 -1.15 -0.75 -1.3 -1.12 -1.13 -0.89 -1.2 -1.46 -1.03 -1.21 -1.12 -1.09 -0.68 -1.04 -1.07 -1.47 -1.21 -1.3 -1.12 -2.04 -1.5 -1.74 -1.87 - -1.23 -1.18 - - - - - - - - -

ROE %

-21.50 -18.55 -15.18 175.55 369.93 377.85 200.46 209.92 30.10 45.20 59.17 68.94 82.28 85.53 91.53 101.60 103.46 100.55 105.64 173.61 262.71 324.03 417.77 245.02 71.75 -64.92 -247.79 -191.55 -143.19 -99.12 -54.44 -53.66 -63.43 -69.53 -74.97 -78.72 -78.06 -78.56 -81.80 199.16 459.10 707.85 917.43 658.67 417.53 188.87 - - - - - - - -

ROA %

-12.03 -10.97 -9.77 110.29 232.51 233.74 110.49 101.94 -26.88 -36.82 -50.76 -54.67 -61.61 -62.81 -59.27 -62.86 -61.45 -57.79 -57.84 -50.75 -47.06 -44.61 -38.47 -49.20 -53.75 -61.48 -64.66 -55.50 -45.66 -38.03 -29.83 -34.23 -44.68 -53.16 -60.72 -64.82 -65.19 -66.56 -70.18 -226.22 -373.24 -510.72 -620.74 -445.66 -282.50 -127.79 - - - - - - - -

ROCE %

-20.70 -18.34 -16.04 -18.99 -18.39 -6.03 14.24 30.83 50.35 65.09 76.98 85.57 94.23 96.64 98.03 104.37 108.28 103.49 112.54 202.40 294.32 369.76 462.79 272.67 102.13 -48.82 -225.84 -173.62 -133.69 -90.71 -51.53 -57.96 -66.13 -71.20 -74.84 -74.58 -74.13 -75.06 -80.24 201.21 459.62 707.85 917.43 658.67 417.53 188.87 - - - - - - - -

Current Ratio

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

- - - - - - - - - - - - - - - - - - 0.1 0.7 0.4 6.3 3.6 4.4 2.4 15.8 45.5 48.1 58.6 42.9 10.4 3.1 10.8 6.4 45.0 16.4 24.6 4.9 18.4 4.2 8.9 23.6 103.8 756.6 3631.8 412.7 - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - - - - - - - 0.1 0.7 0.4 6.3 3.6 4.4 2.4 15.8 45.5 48.1 58.6 42.9 10.4 3.1 10.8 6.4 45.0 16.4 24.6 4.9 18.4 4.2 8.9 23.6 103.8 756.6 3631.8 412.7 - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - - - - - - - 0.1 0.7 0.4 6.3 3.6 4.4 2.4 15.8 45.5 48.1 58.6 42.9 10.4 3.1 10.8 6.4 45.0 16.4 24.6 4.9 18.4 4.2 8.9 23.6 103.8 756.6 3631.8 412.7 - - - - - - - -

Все данные представлены в валюте USD